Isolation of cells. Primary human mononuclear cells were isolated from tonsils obtained from patients undergoing tonsillectomy. The particular number of samples per experiment were detailed in the corresponding Figure legends. Tonsillar mononuclear cells (TMC) were prepared as follows. Briefly, tonsils were collected in phosphate buffered saline (PBS) buffer containing 50 µg ml-1 amphotericin B (Richet, BA, Arg). Tissues were chopped with a scalpel and passed through a 70 µm-pore-size cell strainer (Falcon, Thermo Fisher, BA, Arg). TMC were purified by density gradient centrifugation with Ficoll-Hypaque (GE Healthcare, Uppsala, Sweden). The viability of primary cells, as determined by trypan blue exclusion was greater than 99% in all preparations. Informed consent was obtained from subjects before the study. The institutional ethics committee (Clinical Hospital, School of Medicine, Buenos Aires) approved the collection and use of clinical material, conformed to the provisions of the Declaration of Helsinki (as revised in Edinburgh 2000). Informed consent was obtained from all participants and/or their legal guardian/s. FACS experiments were performed with freshly isolated cells and cultured cells.
Antibodies and fluorescence-activated cell sorting (FACS). Fluorochrome conjugated mAbs specific for human CD3 (Pacific Blue, clone SK7, BioLegend), human CD20 (FITC, clone L27 and APC H7 clone 2H7), human CD4 (PerCP, clone SK3, BioLegend), CD8 (APC Cy7 clone SK1, BioLegend), CD39 (APC, clone TU66, BD Pharmingen), CD73 (PE, clone AD2, BD Pharmingen), CD27 (FITC, clone M-T271, BD Pharmingen), CD38 (APC, clone HIT2, BD Pharmingen), CD44 (Bv510, clone IM7, BioLegend), CXCR5 (AF488 clone RF8B2, BD Pharmingen), PD1 (Bv711, clone EH12.2H7, BioLegend), CD10 (PE, clone ALB1, Beckman Coulter), and respective isotype control mAbs were purchased from BD Biosciences (CA, USA) and Biolegend (CA, USA).
To detect Ki 67 transcription factor in the cells, the latter were incubated with Fixation/Permeabilization (eBioscience FOXP3/Transcription, Invitrogen) for 45 minutes and washed with Permeabilization Buffer (eBioscience FOXP3/Transcription, Invitrogen). Then, the cells were stained with anti-Ki67 mAb.
Cells were acquired using FACSAria II (BD Biosciences, CA, USA) and analyzed with FlowJo software (Treestar, OR, USA). Single stained controls were used to set compensation parameters. Fluorescence minus one and isotype-matched Ab controls were used to set analysis gates.
Immunohistochemistry. The 5 μm tissue sections mounted on silanized glass slides were deparaffinizated by two consecutive 5 min incubations xylene each, hydrated in decreasing concentrations of alcohol (100%, 96% and 70%) for 5 min each, followed by antigenic unmasking with Sodium Citrate Buffer (0,05 M, pH 6.0) in a thermostatic wáter bath at 95°C for 45 min.
The endogenous peroxidase was blocked by incubating tissue sections with 35% H2O2, 98.8% methanol PA (Synth) diluted in PBS pH 7.6 for 30 min, then washed with PBS-1X pH 7.6. The nonspecific binding sites were blocked with Bovine Serum Albumin (BSA) 5%. Ki67+ cells were detected by incubating with the primary antibody. The antibody dilution was 1/100 Ki-67 (Rabbit monoclonal clon SP6, TecnoLab, 275R-15). Slides were incubated one hour at 4°C and washed three times with PBS 1X, pH 7.6.
For the immunohistochemical staining system and counterstaining with hematoxylin, a fully automatic staining device, the Ventana BenchMark XT (Ventana Medical Systems, Roche Diagnostics Division) was used. The device uses a biotin-free, HRP multimer-based hydrogen peroxide substrate and 3, 3’-diaminobenzidine tetrahydrochloride (DAB) chromogen (UltraVIEW Universal DAB Detection, Catalog number 760-500, Ventana Medical Systems, Tucson, USA)
The slides were examined using the Leica DM500 optical microscope (Leica Camera, Wetzlar, Alemania) at magnification of 20x and 40x.